D Westermann, S Van Linthout, S Dhayat, N … - Basic research in cardiology, 2007 - Springer D.Westermann · S.Van Linthout · S. Dhayat · N. Dhayat · M. Noutsias · F.
Spillmann · A. Riad · H.-P. Schultheiss · C. Tschöpe, MD ( ) Dept. of
Cardiology and Pneumonology Charité – Universitätsmedizin Berlin Campus ... Cited by 21 - Related articles - BL Direct - All 5 versions
CS Thompson - Current pharmaceutical design, 2008 - ingentaconnect.com Abstract: The prevalence of diabetes mellitus is increasing worldwide at an
alarming rate due to population growth, obesity, sedentary lifestyle and aging.
Consequently, diabetic microvascular complications (retinopathy and ... Cited by 10 - Related articles - BL Direct - All 3 versions
D Westermann, A Riad, O Lettau, A Roks, K … - Hypertension, 2008 - Am Heart Assoc Pharmacological renin inhibition with aliskiren is an effective antihypertensive
drug treatment, but it is currently unknown whether aliskiren is able to
attenuate cardiac failure independent of its blood pressure–lowering ... Cited by 10 - Related articles - All 5 versions
D Westermann, A Riad, U Richter, S Jäger, K … - Basic Research in Cardiology, 2009 - Springer Abstract Background Diastolic heart failure is a rising problem with a high
incidence and similar mortality and morbidity compared to patients with systolic
heart failure. Never- theless, the underlying pathophysiology is still ... Cited by 3 - Related articles - All 3 versions
A Reddy, KV Ramana, S Srivastava, A … - Endocrinology, 2009 - Endocrine Soc Chronic low-grade inflammation has emerged as a key contributor to the
cardiovascular complications of diabetes, however, the mechanisms by which
diabetes increases inflammation remain poorly understood. Here, we report ... Cited by 3 - Related articles - All 3 versions
C Tschöpe, D Westermann - Biological chemistry, 2008 - reference-global.com Diabetic cardiomyopathy is a specific cardiomyopathy which develops in patients
with diabetes mellitus in the absence of coronary atherosclerosis and
hypertension. Despite the potential importance of this disease entity, the ... Cited by 1 - Related articles - BL Direct - All 3 versions
A Riad, T Walther, J Yang, C Altmann, F … - International Immunopharmacology, 2008 - Elsevier The cytokine interleukin 1ß (IL-1ß) and the bradykinin receptors 1 (B1R) and 2
(B2R) are known to be upregulated in the ischemic heart. In the present study we
investigated whether or not there is a causal link between these entities. ... Cited by 1 - Related articles - All 2 versions
D Westermann, O Lettau, M Sobirey, A Riad, M … - Biological chemistry, 2008 - reference-global.com Clinical use of the anthracycline doxorubicin (DOX) is lim- ited by its
cardiotoxic effects, which are attributed to the induction of apoptosis. To
elucidate the possible role of the kinin B1 receptor (B1R) during the ... Cited by 1 - Related articles - BL Direct - All 6 versions
R Harmancey, H Taegtmeyer - Current Diabetes Reports, 2008 - Springer Introduction Diabetes mellitus is one of the major causes of premature death and
disability, mainly due to cardiovascular com- plications. With the depressing
forecast of 366 million people suffering from diabetes by 2030, the ... Cited by 1 - Related articles - All 2 versions
D Westermann, A Riad, O Lettau, A Roks, K … - Hypertension, 2008 - pt.wkhealth.com Pharmacological renin inhibition with aliskiren is an effective antihypertensive
drug treatment, but it is currently unknown whether aliskiren is able to
attenuate cardiac failure independent of its blood pressure-lowering ... Related articles - All 2 versions
